SILDENAFIL CITRATE
- Product NDC
- 70934-903
- Requested package NDC
- 70934-903-15
- 11-digit product format
- 709340903
- Labeler code
- 70934
- Product ID
- 70934-903_cd872e42-1bc7-2863-e053-2995a90a429b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SILDENAFIL
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA091448
- Marketing category
- ANDA
- Marketing start
- 2021-09-27
- Marketing end
- 0000-00-00
- Substance
- SILDENAFIL CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70934-903 | 70934-903-15 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091448-001 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 25MG BASE | TABLET / ORAL | AB | 2018-06-11 | |
| A091448-002 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 50MG BASE | TABLET / ORAL | AB | 2018-06-11 | |
| A091448-003 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 100MG BASE | TABLET / ORAL | AB | 2018-06-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091448-001 | AB |
| A091448-002 | AB |
| A091448-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091448-001 | SILDENAFIL CITRATE | EQ 25MG BASE | TABLET / ORAL | AB | 2018-06-11 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091448-002 | SILDENAFIL CITRATE | EQ 50MG BASE | TABLET / ORAL | AB | 2018-06-11 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091448-003 | SILDENAFIL CITRATE | EQ 100MG BASE | TABLET / ORAL | AB | 2018-06-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091448-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091448-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091448-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sildenafil Citrate | SILDENAFIL | Proficient Rx LP | 3522bdcc-8113-4562-8ca1-f3eb884beaea | 2026-06-01 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | PD-Rx Pharmaceuticals, Inc. | ace2bb56-4992-49fe-9311-535b12eea9b4 | 2026-05-27 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | PD-Rx Pharmaceuticals, Inc. | 78c4551c-b922-43c9-9a5a-66377ea07bc2 | 2026-05-27 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Redpharm Drug | 52614168-3a9e-335d-e063-6394a90ac27f | 2026-05-22 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | NuCare Pharmaceuticals, Inc. | 36da8e3a-d17c-e42f-e063-6394a90a1ece | 2026-05-18 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Preferred Pharmaceuticals Inc. | 5f9ff0bb-5634-437a-96eb-249b910c7e81 | 2026-04-22 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Bryant Ranch Prepack | a05ab4e7-6f70-41c3-a3b7-9a2fd7a1d2d6 | 2026-03-30 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Bryant Ranch Prepack | edb0919d-cbf1-4968-b0eb-342aa811c2ce | 2026-03-09 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Torrent Pharmaceuticals Limited | b48630b1-5208-4d00-b56f-21701f223758 | 2026-02-10 | Warnings, Adverse reactions | 091448 ANDA091448 |
| SILDENAFIL CITRATE | SILDENAFIL | Northwind Health Company, LLC | d9de0817-cac1-4ee5-e053-2a95a90a5fa7 | 2026-01-01 | Warnings, Adverse reactions | 091448 ANDA091448 |
FDA-Initiated Inactive NDC Indexing#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70934-903-15 | 70934090315 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-903-15) | 2021-09-27 | 0000-00-00 | No | No | Current |